SuperDerivatives Readies Beta DGX Real-Time OTC Derivatives Terminal

Derivatives pricing, data and risk management software provider SuperDerivatives is planning to release a beta-testing version of its new DGX data display platform by year-end to clients of its SDX multi-asset structured products pricing platform.

Since announcing in June that it would develop a web-based market data terminal to deliver real-time, streaming price updates for over-the-counter derivatives (IMD, July 12), SuperDerivatives has secured distribution deals with an unnamed newswire to provide news widgets for DGX, and with an unnamed provider of video content covering the stock markets. The vendor is also currently in negotiations with a data and investment research provider to supplement its proprietary derivatives prices with market data on other asset classes to broaden the scope of the platform.

“Obviously the derivatives coverage is the distinguishing feature as we have much greater depth of coverage than traditional terminal providers, but we want the platform to do everything, so we are also providing prices, fundamentals, data and research covering other asset classes such as equities and cash products,” says David Collins, head of strategic development at SuperDerivatives.

As well as streaming price updates, DGX includes an app store that will enable third-party software vendors to create applications to deliver content sets not available in the basic terminal offering—for example, specialized news, economic analysis or corporate actions data—to which DGX clients will be able to instantly subscribe via chargeable apps that can be integrated as widgets into the platform.

In premium products, “everyone gets all the data, but not everyone needs it, so we created the app store on the platform to provide additional functionality,” enabling clients to subscribe to only the specific data they want, Collins says.

Additional features of the platform include a fully customizable dashboard, with widgets displaying OTC derivatives prices (as well as other asset classes), interest rates, FX rates, charts and news, as well as an alert functionality that notifies users when complex derivatives products are traded, and a chat function to support interaction between market participants.

Initially, the web-based DGX platform will be available free of charge to any SuperDerivatives client with an existing license for the vendor’s SDX multi-asset platform for pricing structured products. However, after an introductory period, the vendor plans to price access to the platform at around $2,500 per year, Collins says.

In the meantime, Collins says Super­Derivatives will continue to conduct final development—including enhancing the sophistication of the platform’s Google-like search engine functionality, which will enable users to search for any data available in the terminal using free-text searches—and internal testing on DGX, in preparation for a beta launch scheduled for November or December.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Enough with the ‘Bloomberg Killers’ already

Waters Wrap: Anthony interviews LSEG’s Dean Berry about the Workspace platform, and provides his own thoughts on how that platform and the Terminal have been portrayed over the last few months.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here